What is the main business of Ortie Capital Investment?

The main business activity of Ortie Capital Investment focuses on activities of head offices.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 30, 2004.

Where is the headquarters located?

The headquarters is located at: Hubska 44, 50-502 Wrocław.

Who is on the management board?

The management board includes Paweł Andrzej Szewczyk (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 10,000,000 (approx. $2.7 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $3,427,845, representing an increase of 40.2% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $2,445,437, meaning the company increased its profit by 57.2%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $328,636 in 2024, representing 43% of all operating expenses.

Ortie Capital InvestmentS.A.

Activities of head offices

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-04-30

Share capital

10 000 000,00 PLN

Activity description

Ortie Capital Investment is a private equity and venture capital fund that invests in early-stage companies across various sectors, including medical services, medical equipment production, healthcare, pharmaceuticals, sports and recreation, logistics, and financial services. The fund provides both financial and managerial support, with investments ranging from 300,000 to 3 million PLN and an average investment duration of up to three years. Current investments include NETTLE S.A., which offers healthcare services and dedicated distribution processes for pharmaceuticals to hospitals and pharmacies.

Registered address

Hubska 44, 50-502 Wrocław, Poland

Website

ortie.pl

Phone

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 7.77mMedianUSD 113.57kAverageUSD 43.33m

Net profit

This companyUSD 6.30mMedianUSD 867.57AverageUSD -245.44k

Operating costs

This companyUSD 908.52kMedianUSD 42.43kAverageUSD 40.83m

Assets

This companyUSD 95.29mMedianUSD 516.69kAverageUSD 93.44m

Industry

Bank accounts

Registered as a VAT taxpayer on 2004-09-24. Active

ING Bank Śląski
12 1050 1575 1000 0090 8481 3501
Alior Bank
11 2490 0005 0000 4530 6893 8851
Alior Bank
39 2490 0005 0000 4600 3474 2408

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

6 notices recorded in the Court and Commercial Gazette (MSiG).

Publication date	Event
Dec 7, 2020	Commercial Companies Code notice
Nov 20, 2020	Commercial Companies Code notice
Nov 5, 2020	Commercial Companies Code notice
Oct 21, 2020	Commercial Companies Code notice
Sep 23, 2020	Commercial Companies Code notice

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,211	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$6,182	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,095	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Authorized Representatives

Paweł Andrzej Szewczyk — President of the Management Board

Barbara Wojtas — Attorney-in-fact (joint)

Piotr Król — Vice President of the Management Board

Manner of representation

For representing the company in external relations, that is, for making declarations of will on its behalf and signing documents producing legal effects, the following are authorised: 1) in the case of a one-person management board, the sole member of the management board, independently; 2) in the case of a multi-member management board, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Supervisory board

Krzysztof Bernard Wojtas — Supervisory Board Member

Wiesław Lech Bociek — Supervisory Board Member

Marcin Dworniczak — Supervisory Board Member

Beneficial owners

Person	Rights
Piotr Król (56)	Other natural person.
Paweł Andrzej Szewczyk (56)	Other natural person.

Subsidiaries

	Name	Share value	Stake
	ERG Medicalsp. z o.o.	5,213.40 USD	19.8969%
	Nesselsp. z o.o.	—	—

Competitors

Name	Revenue	Website
Adamed Technologysp. z o.o.	$8,360,772.47	adamedtechnology.com
Enterprise Investorssp. z o.o.	$8,341,621.14	ei.com.pl
Radix Advisorssp. z o.o.	$1,230,819.85	radix-vc.com
InvestcareS.A.	$1,113,164.45	grupainvestcare.pl
JET Investment Polandsp. z o.o.	$780,088.88	jetinvestment.cz

Change history

Date	Event
2018-11-20	PKD change (Removed: 22, 40, 45, 51, 51.1, 52, 55, 63.1, 63.3, 65.21, 65.22.Z, 65.23.Z, 67.13, 67.13.Z, 70, 70.2, 72, 73, 74.13, 74.14, 74.2, 74.3, 74.4, 74.81, 74.83, 74.84.A, 80.4, 92.31.E, 93.04; Added: 64.20.Z, 64.92.Z, 68.20.Z, 69.10.Z, 70.10.Z, 77.11.Z)
2018-02-02	Share capital change (13,200,000.00 PLN → 10,000,000.00 PLN)
2017-10-24	Share capital change (10,000,000.00 PLN → 13,200,000.00 PLN)
2008-05-29	PKD change (Added: 69.20.Z, 70.22.Z, 78.10.Z, 78.30.Z)
2007-09-26	Share capital change (8,959,600.00 PLN → 10,000,000.00 PLN)

FAQ

Last updated: 2026-07-09